Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development

14 Mar 2018

Abstract excerpt

. It is generally assumed that a single infection with LASV will produce life-long protective immunity. This suggests that protective immunity induced by vaccination is an achievable goal and that cell-mediated immunity may play a more important role in protection, at least following natural infection. Seropositive individuals in endemic regions have been shown to have LASV-specific T cells recognizing epitopes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral Infections and Outbreaks Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29581897
DOI: 10.1038/s41541-018-0049-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and developmentPMID 29581897Read ↗

Lassa virus diversity and feasibility for universal prophylactic vaccineSemantic proximity Read ↗

Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shotSemantic proximity Read ↗

Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developmentsSemantic proximity Read ↗

Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.Semantic proximity Read ↗

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteinsSemantic proximity Read ↗

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa feverSemantic proximity Read ↗

A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigsSemantic proximity Read ↗

Spatio-temporal spread and evolution of Lassa virus in West AfricaSemantic proximity Read ↗

A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.Semantic proximity Read ↗

Challenges, Progress, and Pathways to Equitable ACCESS in Lassa Fever Vaccine DevelopmentSemantic proximity Read ↗

Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primatesSemantic proximity Read ↗

A Mutation-Based Reverse Vaccinology Approach Considering Variability in Epitopes to Combat Multi-Strains: A Study Using Glycoprotein of LASV.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.